Optic nerve damage and atrophy (ONA) due to inflammation, ageing and atherosclerosis, optic nerve atrophy due to glaucoma, and ischaemic optic neuropathy, are caused, among other things, by impaired blood supply, poor oxygenation and inflammation.
In these cases, low-frequency pulsed magnetic therapy and its strong vasodilatory effect on the pre-capillary arterioles and capillaries, which improves the microcirculation of oxygenated blood and nutrient supply, can be used as a complementary and maintenance therapy.
The increased metabolic rate and anti-inflammatory effect improve the course of optic nerve atrophy and have a positive effect on impaired retinal rod function in patients with night blindness (nyctalopia).
Read the results of the following clinical study that demonstrate the success rate of low-frequency pulsed magnetic therapy in treatment of this condition.
Related diagnosis: Optic nerve atrophy, nyctalopia